Millennium Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Millennium Management’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,008	Closed	-$9K	–	7138
2023 Q1	$9K	Sell	2,008 -1,136	-36%	-$6.39K	﹤0.01%	6061
2022 Q4	$14K	Sell	3,144 -5,830	-65%	-$37.6K	﹤0.01%	6138
2022 Q3	$163K	Buy	8,974 +2,189	+32%	+$76.7K	﹤0.01%	5768
2022 Q2	$342K	Buy	6,785 +6,167	+998%	+$459K	﹤0.01%	5258
2022 Q1	$87K	Buy	618 +395	+177%	+$57.7K	﹤0.01%	6214
2021 Q4	$38K	Buy	+223	New	+$83.1K	﹤0.01%	6533
2021 Q2	–	Sell	-6,368	Closed	-$3.23M	–	7355
2021 Q1	$3.23M	Buy	6,368 +5,458	+600%	+$2.81M	﹤0.01%	3058
2020 Q4	$434K	Buy	910 +876	+2,576%	+$287K	﹤0.01%	4307
2020 Q3	$10	Buy	+34	New	+$8.43K	﹤0.01%	4373
2020 Q1	–	Sell	-213	Closed	-$37K	–	4729
2019 Q4	$37K	Sell	213 -285	-57%	-$36.8K	﹤0.01%	4114
2019 Q3	$74K	Sell	498 -5,827	-92%	-$776K	﹤0.01%	4005
2019 Q2	$736K	Buy	+6,325	New	+$1M	﹤0.01%	2991
2018 Q2	–	Sell	-2,608	Closed	-$2.66M	–	4312
2018 Q1	$2.66M	Buy	2,608 +1,990	+322%	+$1.67M	﹤0.01%	2162
2017 Q4	$755K	Sell	618 -566	-48%	-$266K	﹤0.01%	2875
2017 Q3	$217K	Sell	1,184 -356	-23%	-$56.4K	﹤0.01%	3205
2017 Q2	$241K	Buy	+1,540	New	+$311K	﹤0.01%	3123
2016 Q3	–	Sell	-58	Closed	-$23K	–	3721
2016 Q2	$23K	Buy	+58	New	+$63.3K	﹤0.01%	3100
2016 Q1	–	Sell	-175	Closed	-$183K	–	3780
2015 Q4	$183K	Sell	175 -447	-72%	-$442K	﹤0.01%	3124
2015 Q3	$539K	Buy	622 +39	+7%	+$32.6K	﹤0.01%	2614
2015 Q2	$415K	Buy	+583	New	+$621K	﹤0.01%	2727
2015 Q1	–	Sell	-69	Closed	-$71K	–	4256
2014 Q4	$71K	Buy	+69	New	+$73.7K	﹤0.01%	3806
2014 Q3	–	Sell	-268	Closed	-$670K	–	4094
2014 Q2	$670K	Buy	268 +65	+32%	+$133K	﹤0.01%	2417
2014 Q1	$386K	Buy	+203	New	+$480K	﹤0.01%	2784

Other funds holding AMPE

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Millennium Management's AMPE Position: Q2 2023 in Review

Millennium Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2023, closing a stake of 2,008 shares — an estimated $9K sold.

Millennium Management first reported a position in AMPE in Q1 2014 and held it in 23 quarters. The position peaked at $3.23M in Q1 2021. 34 funds tracked by Wall St. Rank hold AMPE as of Q2 2023.

Millennium Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
Millennium Management sold 2,008 Ampio Pharmaceuticals Inc. shares in Q2 2023, an estimated $9K.
Millennium Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 23 quarters.
Millennium Management's Ampio Pharmaceuticals Inc. position peaked at $3.23M in Q1 2021.
34 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.